Abiopharma

LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Symbol	LFCR
Name	LIFECORE BIOMEDICAL, INC. \DE\
Sector	UNDEFINED
Region	UNDEFINED
Industry	Pharmaceutical Preparations
Address	3515 LYMAN BOULEVARD, CHASKA, MN 55318
Telephone	9523684300
Fax	—
Email	—
Website	—
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001005286
Description	None

2026-08-05 11:05

Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update

2026-07-29 20:05

Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026

2026-07-28 11:05

Lifecore Biomedical Signs Three New Customer Agreements

2026-07-15 20:05

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2026-07-02 21:17

(99% Neutral) LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Announces Regulatory Update

2026-07-02 18:37

New Form SCHEDULE 13D/A - LIFECORE BIOMEDICAL, INC. \DE\ Filed: 2026-07-02 AccNo: 0000921895-26-001747 Size: 23 KB

2026-07-02 18:15

New Form SCHEDULE 13D/A - LIFECORE BIOMEDICAL, INC. \DE\ Filed: 2026-07-02 AccNo: 0001193125-26-294951 Size: 23 KB

2026-06-15 11:05

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company

2026-06-08 20:37

Director Kiper Christopher S 🟢 acquired 25.9K shares of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Transaction Date: Jun 04, 2026 | Filing ID: 001575

2026-06-05 20:47

Director OBUS NELSON 🟢 acquired 25.9K shares of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Transaction Date: Jun 04, 2026 | Filing ID: 000002